The combination of a weak outlook for bonds and research that investors close to retirement are OK with more risk leads Fidelity to tilt its target date funds more toward stocks.
Strategist Bob Doll lends investment expertise to offering expected in early 2014.
Stocks could lose 40% to 50% of value over next few years, analyst says
Deal adds six equities strategies, pushes firm over $500M in assets.
ETFs can help investors remain 'agile and active,' COO says.
Even though the partial shutdown of the government is set to give way to a prolonged — and probably nasty — debt-ceiling debate, now is not the time to bail from the markets.
Returns from the stock market's four-year rally match those of the late-1990s advance, but valuations are lagging. Bulls say that means there's more room to run; bears have a compelling counter argument.
Analyst says rally based on rising interest rates, a likelihood pushed into future.
The Fed's unexpected change of heart has some advisers looking for a near-term rally in bonds. Jeff Benjamin has the story.
King Pharmaceuticals-Pfizer deal led to nearly $500,000 in illegal profits, agency claims.
Study by Harold Evensky finds that belief is more sales pitch than reality.
Live from the <i>IN</i> Alternatives Investments Conference: Low rates, economic uncertainty and surprises have pushed asset classes in the same direction
Continuing QE is both an economic and psychological drag
A new polls finds that most investors don't think the markets will be roiled if the Federal Reserve begins to cut back its asset purchases - the much talked-about tapering - next week. Is a rally possible?
Is the 'great rotation' beginning with the high net worth crowd?
IPO debacle of social media darling led to losses of almost $500 million.
